Febrile seizures lead to prolonged epileptiform activity and hyperoxia that when blocked prevents learning deficits

Sydney A Harris1,2, Antis G George1, Karlene T Barrett1,2,3

  • 1Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.

Epilepsia
|July 19, 2022
PubMed

Insights

Febrile seizures in juvenile rats cause rapid brain oxygen changes. Targeting TRPV1 receptors during seizures prevented long-term learning deficits, suggesting a novel therapeutic approach.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Biomedical Engineering

Background:

  • Adult brain oxygenation is typically normoxic, but seizures cause dynamic changes (hyperoxia/hypoxia).
  • Mechanisms of oxygen level fluctuations during juvenile febrile seizures remain largely unknown.

Purpose of the Study:

  • Investigate dynamic changes in brain oxygen partial pressure (pO2) during and after febrile seizures in juvenile rats.
  • Elucidate the underlying mechanisms of these oxygen dynamics.
  • Assess the long-term impact of febrile seizures on learning and potential therapeutic interventions.

Main Methods:

  • Implanted electrodes and oxygen-sensing optodes in the hippocampus of 8-day-old rat pups.
  • Induced immune response and febrile seizures using lipopolysaccharide and heat.
  • Recorded local pO2 and field potentials before, during, and after seizures.
  • Administered antagonists/agonists for COX-1, COX-2, LTCCs, CB1, and TRPV1 receptors.
  • Evaluated learning deficits using the novel object recognition task in adulthood.

Main Results:

  • Febrile seizures induced rapid pO2 fluctuations (increase, decrease, return to baseline).
  • Hyperoxia occurred during prolonged epileptiform activity post-seizure.
  • COX-1 antagonism prevented hyperoxia; LTCC antagonism exacerbated it.
  • Endocannabinoid system modulation affected hyperoxia; CB1 and TRPV1 receptor blockade reduced it.
  • TRPV1 receptor inhibition during seizures prevented subsequent learning impairments in female rats.

Conclusions:

  • Febrile seizures in juveniles exhibit distinct brain oxygenation patterns with complex mechanisms.
  • Targeting specific pathways, like TRPV1 receptors, may mitigate long-term consequences of febrile seizures.
  • Brain oxygen dynamics are a critical factor for developing effective febrile seizure treatments.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
271
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
575
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
1.5K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
598
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
428
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
269